Øyvind M.
- Country
- Norway
- Department
- 2401: Department of rheumatology dermatology, and infectious disease
Research Overview
- Phase 3 Randomized Double-blind Placebo-controlled Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
- OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study
- Evaluation of Rapcabtagene Autoleucel Versus Standard of Care in Systemic Lupus Erythematosus Patients with Active, Refractory Lupus Nephritis
Data & Insights
Has run more than one trial at 58 of 195 partner sites.
Specializations
Autoimmune Disease Research
The investigator specializes in studying systemic lupus erythematosus (SLE), with particular emphasis on cases involving active lupus nephritis. Their work focuses on understanding autoimmune responses affecting kidney function in SLE patients.
- Lupus Nephritis Management
- Refractory Disease Treatment
- Autoimmune Kidney Disorders
The investigator explores innovative therapeutic approaches for patients with treatment-resistant forms of lupus nephritis.
Cell Therapy Innovation
Their research interests include the application of autologous cell therapy in autoimmune conditions, specifically investigating rapcabtagene autoleucel as a therapeutic intervention for severe lupus manifestations.
- CAR T-Cell Applications
- Cellular Immunotherapy
- Advanced Therapeutic Development
The investigator evaluates novel cellular approaches compared to standard treatment protocols in autoimmune diseases.
Clinical Response Assessment
The investigator focuses on evaluating long-term clinical responses in refractory autoimmune conditions, with expertise in assessing therapeutic outcomes over extended periods.
- Treatment Response Metrics
- Long-term Outcome Analysis
- Comparative Treatment Studies
Their work includes systematic evaluation of treatment efficacy in complex autoimmune presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.